• Title/Summary/Keyword: Product Liability (PL)

Search Result 102, Processing Time 0.019 seconds

A Study on the PL Response by Integrated Management System (통합경영 시스템을 통한 PL 대응 방안 연구)

  • Kim, Kwang-Soo;Lim, Gab-Chul;Chung, Soon-Suk
    • Journal of Korean Society for Quality Management
    • /
    • v.39 no.1
    • /
    • pp.120-130
    • /
    • 2011
  • The purpose of this study is to offer the integrated model of the product safety management system, ISO 9001 Quality Management System, ISO 14001 environmental management system and OHSAS 18001 Occupational Health and Safety Management System and to present its management plan. In order to cope with effectuation of the Product Liability, studies were conducted to construct an integrated system and to find strategies of companies.

A Study of PL Prevention System in the USA and Japanese Leading Enterprises (美.日 선진기업의 PL 대응 시스템에 대한 연구)

  • 홍한국;박상찬
    • Journal of Korean Society for Quality Management
    • /
    • v.27 no.3
    • /
    • pp.189-201
    • /
    • 1999
  • On November, 1998, Ministry of Finance and Economy in Korea announced officially to enforce the PL(Product Liability) Law within the country at the first half of the year 2000. Therefore, a companys responsibility for customers who are damaged by a defect in the products safety will be gradually strict and impose burden on management. This paper presents suggestions about PL prevention of domestic enterprise through the research of PL prevention strategies and prevention systems in the USA and Japanese leading enterprises.

  • PDF

제조물책임(법)의 시행과 컨설팅업체의 역할

  • 고병인;임현교
    • Proceedings of the Korean Institute of Industrial Safety Conference
    • /
    • 2002.05a
    • /
    • pp.499-502
    • /
    • 2002
  • 오랜 기간의 검토 끝에 오는 7월 1일 제조물책임(Product Liability, 이하 PL)법의 시행을 앞두고 있다. PL법은 그 목적에서 밝히고 있듯이 제조물의 결함으로 인하여 발생한 손해에 대해 제조업자 등의 손해배상책임을 규정함으로써 피해자의 보호를 도모하고 국민생활의 안전향상을 도모하기 위한 것이다.(중략)

  • PDF

A Study on the Case of PL Prevention Strategies for Diary Manufacturing Company (PL대응전략 사례 연구 : 국내 유가공 생산업체 중심으로)

  • Hong, Han-Kuk;Kim, Chul-Min
    • Journal of Korean Society for Quality Management
    • /
    • v.34 no.4
    • /
    • pp.51-64
    • /
    • 2006
  • The PL (Product Liability) Law has been going into effect in Korea since July 2002. Accordingly, a company's responsibility for customers who are damaged by the defect in the product safety has been gradually strict and imposed burden on management. This paper presents suggestions as to PL prevention of diary manufacturing companies through the case research of PL prevention strategies and the prevention systems of the domestic diary manufacturing company.

Classification of Product Liability Case (제조물책임(PL)사례의 유형화 분석)

  • 최성운;김성철
    • Proceedings of the Safety Management and Science Conference
    • /
    • 2000.05a
    • /
    • pp.175-192
    • /
    • 2000
  • 본 논문은 우리나라에서도 2002년 7월1일 시행하게될 제조물책임법(PL)에 대비해 최근 우리나라 및 선진국인 미국, 일본을 중심으로 조사된 최근 사례를 결함별, 제품별, 국가별로 유형화하여 분석한다. PL법이 시행되기 전 많은 사례들이 발생하여 소송으로 제기되었고, 각 나라는 많은 시행착오를 거쳐 지금의 제조물책임(PL)을 수정, 보완되고 있는데 이러한 측면에서 외국의 사례와 우리나라의 사례를 비교, 유형화시켜 분석하고자 한다.

  • PDF

Pharmaceutical Product Liability and the Burden of Proof (혈액제제 제조물책임 소송과 증명책임 -대법원 2011. 9. 29. 선고 2008다16776 판결과 관련하여-)

  • Moon, Hyeon-Ho
    • The Korean Society of Law and Medicine
    • /
    • v.12 no.2
    • /
    • pp.65-117
    • /
    • 2011
  • This article analyzes the case (2008Da16776) which has the issue how patients have to prove causal relationship when patients claim against pharmaceutical companies alleging that patients were infected with virus due to contaminated blood products. The Supreme court held that: (1) if patients prove that they didn't have symptoms suggesting virus infection before administration of blood products, the virus infection had been confirmed after administration of blood products, and there were significant potential of contamination of the blood products with the virus, the defect in blood products or the negligence of pharmaceutical company in making blood products shall be presumed to cause the infection of the victim. (2) The pharmaceutical companies could reverse the presumption by proving the blood products were not contaminated, but the fact that the victims were treated with the blood products manufactured by other companies or had received blood transfusions is not enough to reverse the presumption. The case is the first decision whether the burden of proof about causal relationship could be reduced in pharmaceutical product liability lawsuit. Hereafter pharmaceutical product liability cases, it would be necessary to reduce the burden of proof about causal relationship in order to make substantive equality between patients and pharmaceutical companies.

  • PDF

The Selection and Assessment system of Manufacturer in the Home Shopping Industry (홈쇼핑 업종에서의 협력업체 선정과 평가체계)

  • Mun, je-ok
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.10 no.4
    • /
    • pp.147-155
    • /
    • 2015
  • Home Shopping companies haven't have any possible means of product quality control process in spite of the fact that they are selling average 16,000 different kinds of product every month. Under this condition, increases of return and product liability can have a strong negative influence on customers' trust in a home shopping brand and intentional repurchase through the same home shopping channel. To solve the problems, we applied adjusted selection and assessment system of manufacturers in home shopping industry, and the consequence of system effect was verified that there is a decrease of 10.3% in the number of returns and a decrease of 11.7% in the number of product liability.

  • PDF

제품위험성분석 사례에 의한 Human Error의 분석

  • 고병인;임현교
    • Proceedings of the Korean Institute of Industrial Safety Conference
    • /
    • 2002.11a
    • /
    • pp.390-393
    • /
    • 2002
  • 올해 7월 1일부터 제조물책임(Product Liability, 이하 PL)법이 시행되기 시작하였다. PL법은 그 목적에서 밝히고 있듯이 제조물의 결함으로 인하여 발생한 손해에 대해 제조업자 등의 손해배상책임을 규정함으로써 피해자의 보호를 도모하고 국민생활의 안전향상을 도모하기 위한 것이다. PL법에서 ‘결함’이라고 하는 것은 설계, 제조 그리고 표시사항의 결함과 통상적으로 기대할 수 있는 안전성이 결여되어 있는 것을 말함으로 기업이 대응하여야 할 범위는 과거에 생각하는 품질의 개념보다 높다고 하겠다.(중략)

  • PDF